Advertisement
100% x 90

Nuchal Translucency Calculator

Assess chromosomal abnormality risk from first trimester ultrasound measurements

Calculate Nuchal Translucency Risk

Fetal length from crown to rump (typically 35-100mm at 11-14 weeks)

Thickness of fluid-filled space at back of fetal neck

Leave empty to auto-calculate from CRL (11-14 weeks = 77-98 days)

Example Calculation

Normal NT at 12 Weeks

Crown-rump length: 60mm

Measured NT: 1.5mm

Expected NT: 0.437 + (0.01969 × 60) = 1.62mm

Gestational age: ~12 weeks 2 days

Result

Percentile: 50th-75th percentile

Risk assessment: Normal range (<95th percentile)

Recommendation: Continue routine prenatal care

Advertisement
100% x 250

NT Risk Categories

<95

Normal Range

<95th percentile

97% normal babies, 0.2% chromosomal abnormalities

95+

Increased Risk

95th-99th percentile

93% normal babies, 3.7% chromosomal abnormalities

3.5+

Elevated Risk

3.5-4.4mm

70% normal babies, 21% chromosomal abnormalities

6.5+

Very High Risk

≥6.5mm

15% normal babies, 64.5% chromosomal abnormalities

NT Reference Guide

Optimal timing:11-14 weeks
CRL range:45-84mm
Normal NT:<95th percentile

Conditions Detected:

  • • Down syndrome (Trisomy 21)
  • • Edwards syndrome (Trisomy 18)
  • • Patau syndrome (Trisomy 13)
  • • Turner syndrome
  • • Cardiac defects

Understanding Nuchal Translucency Screening

What is Nuchal Translucency?

Nuchal translucency (NT) is the measurement of the clear space in the tissue at the back of a developing baby's neck during the first trimester (11-14 weeks). This ultrasound measurement helps assess the risk of chromosomal abnormalities and certain genetic conditions.

Why is NT Screening Important?

  • Early detection of chromosomal abnormalities (Down syndrome, Edwards syndrome)
  • Assessment of cardiac defects and other structural abnormalities
  • Risk stratification for further diagnostic testing
  • Combined screening with maternal blood tests

NT Calculation Formula

Expected NT = 0.437 + (0.01969 × CRL)

  • NT: Nuchal Translucency (mm)
  • CRL: Crown-Rump Length (mm)
  • Percentile: Comparison to population norms

Follow-up Testing

NIPT:Non-invasive blood test
CVS:Chorionic villus sampling
Amniocentesis:Amniotic fluid testing

Important: NT screening is not diagnostic. Abnormal results require additional testing and genetic counseling for definitive diagnosis.

Advertisement
100% x 250